Rivaroxaban as Therapy for Saphenous Venous Graft Failure due to Venous Outflow Mismatch.

Background: Recurrent angina and long-term occlusion following coronary artery bypass graft surgery is often treated with percutaneous coronary intervention, a high-risk intervention for distal embolization. Here, we present the utilization of the novel oral anticoagulant, rivaroxaban, in the treatment of saphenous vein graft thrombosis with complete resolution of the thrombus secondary to graft outflow mismatch. Case Presentation. A 69-year-old man with triple coronary artery bypass grafting using a saphenous vein and left internal mammary artery, performed in 2017, presented at our hospital for recurrent angina. Coronary angiography revealed a patent LIMA to LAD and a large clot burden in the venous conduit to the first OM/terminal circumflex-theorized to be due to an outflow mismatch of the large saphenous vein to the native artery resulting in stasis. Instead of percutaneous coronary intervention, he was treated with rivaroxaban 20 mg once a day. The angiography 4 weeks after starting rivaroxaban showed complete resolution of the thrombus. Conclusion: Rivaroxaban could become a potential treatment option in thrombus reversal due to static venous flow with subsequent long-term patency of the graft. Additionally, its use may be indicated in the generalized prevention of VGF.

Variation in phonological bias: Bias for vowels, rather than consonants or tones in lexical processing by Cantonese-learning toddlers.

Consonants and vowels have been considered to fulfill different functions in language processing, vowels being more important for prosodic and syntactic processes and consonants for lexically related processes (Nespor, Peña, & Mehler, 2003). This C-bias hypothesis in lexical processing is supported by studies with adults and infants in many languages such as English, French, Spanish, although a few studies, on Danish and Mandarin, suggest the existence of cross-linguistic variation. The present study explores whether a C-bias exists in a tone language with a complex tone system, Cantonese, by comparing the relative weight given to consonants, vowels, and also tones during word learning. To do so, looking behaviors of Cantonese-learning 20- and 30-month-olds (24 children per age/condition, 6 groups) were recorded by an eyetracker while they watched animated cartoons in Cantonese to learn pairs of novel words. The words differed minimally by either a consonant (e.g., /tœ6/ vs. /kœ6/), a vowel (e.g., /khim3/ vs. /khɛm3/), or a tone (e.g., T2 vs. T5). Analyses on proportional looking times revealed significant learning in 30-month-olds only, and at that age, only for the vowel contrasts. Growth curve analyses revealed better performance for the vowel condition compared to the other two conditions. The present findings establish a V-bias in Cantonese-learning 30-month-olds, adding new evidence from that tone language that the C-bias in lexical processing is not language-general. Implications for theoretical discussions on the origins of this phonological bias, and the impact of tones in early language acquisition, are discussed.

Fetal Concentrations of Budesonide and Fluticasone Propionate: a Study in Mice.

The study goal was to evaluate the transplacental transfer of two corticosteroids, budesonide (BUD) and fluticasone propionate (FP), in pregnant mice and investigate whether P-glycoprotein (P-gp) might be involved in reducing BUD transplacental transfer. Pregnant mice (N = 18) received intravenously either low (104.9 µg/kg) or high (1049 µg/kg) dose of [3H]-BUD or a high dose of [3H]-FP (1590 µg/kg). In a separate experiment, pregnant mice (N = 12) received subcutaneously either the P-gp inhibitor zosuquidar (20 mg/kg) or vehicle, followed by an intravenous infusion of [3H]-BUD (104.9 µg/kg). Total and free (protein unbound) corticosteroid concentrations were determined in plasma, brain, fetus, placenta, kidney, and liver. The ratios of free BUD concentrations in fetus versus plasma K(fetus, plasma, u, u) 0.42 ± 0.17 (mean ± SD) for low-dose and 0.38 ± 0.18 for high-dose BUD were significantly different from K = 1 (P < 0.05), contrary to 0.87 ± 0.25 for FP, which was moreover significantly higher than that for matching high-dose BUD (P < 0.01). The BUD brain/plasma ratio was also significantly smaller than K = 1, while these ratios for other tissues were close to 1. In the presence of the P-gp inhibitor, K(fetus, plasma, u, u) for BUD (0.59 ± 0.16) was significantly increased over vehicle treatment (0.31 ± 0.10; P < 0.01). This is the first in vivo study demonstrating that transplacental transfer of BUD is significantly lower than FP's transfer and that placental P-gp may be involved in reducing the fetal exposure to BUD. The study provides a mechanistic rationale for BUD's use in pregnancy.

Purification of inkjet ink from water using liquid phase, electric discharge polymerization and cellulosic membrane filtration.

A method to separate inkjet ink from water was developed using a liquid phase, electric discharge process. The liquid phase, electric discharge process with filtration or sedimentation was shown to remove 97% of inkjet ink from solutions containing between 0.1-0.8 g/L and was consistent over a range of treatment conditions. Additionally, particle size analysis of treated allyl alcohol and treated propanol confirmed the electric discharge treatment has a polymerization mechanism, and small molecule analysis of treated methanol using gas chromatography and mass spectroscopy confirmed the mechanism was free radical initiated polymerization.

Hypertriglyceridemia.

Hypertriglyceridemia is a commonly encountered lipid abnormality frequently associated with other lipid and metabolic derangements. The National Cholesterol Education Program recommends obtaining a fasting lipid panel in adults over the age of 20. The discovery of hypertriglyceridemia should prompt an investigation for secondary causes such as high fat diet, excessive alcohol intake, certain medications, and medical conditions (eg, diabetes mellitus, hypothyroidism). In addition, patients should be evaluated for other components of the metabolic syndrome. These include abdominal obesity, insulin resistance, low high-density lipoprotein (HDL), high triglyceride, and hypertension. Hypertriglyceridemia is classified as primary hypertriglyceridemia when there are no secondary causes identified. Primary hypertriglyceridemia is the result of various genetic defects leading to disordered triglyceride metabolism. It is important to treat hypertriglyceridemia to prevent pancreatitis by reducing triglyceride levels to <500 mg/dL. Furthermore, lowering triglycerides while treating other dyslipidemias and components of the metabolic syndrome will reduce coronary events. However, it is controversial how much isolated hypertriglyceridemia correlates directly with coronary artery disease and further studies are needed to clarify whether treatment for this condition leads to meaningful clinical outcomes. Therapeutic lifestyle changes (TLC) are the first line of treatment for hypertriglyceridemia. These changes include a low saturated fat, carbohydrate-controlled diet, combined with alcohol reduction, smoking cessation, and regular aerobic exercise. High doses of omega-3 fatty acids from fish and fish oil supplements will lower triglyceride levels significantly. When patients do not reach their goals by TLC, drug therapy should be started. In cases of isolated hypertriglyceridemia, fibrates are initially considered. When elevated low-density lipoprotein levels accompany hypertriglyceridemia, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are preferred. In patients with low HDL levels and hypertriglyceridemia, extended release niacin can be considered. A combination of the medicines may be necessary in recalcitrant cases.

Patterns of coronary compromise leading to bradyarrhythmias and hypotension in inferior myocardial infarction.

BACKGROUND: Occlusion and reperfusion of the acutely occluded right coronary artery may result in abrupt bradycardia and hypotension, attributed to Bezold-Jarisch cardio-inhibitory reflexes arising from the ischemic left ventricle. Given that right ventricular infarction, a result of proximal right coronary artery occlusion, predisposes to bradycardia and hypotension, we hypothesized that proximal right coronary occlusions would be more likely to result in bradycardia-hypotension compared to more distal occlusions. METHODS: In 216 patients with acute inferior myocardial infarction undergoing primary angioplasty of the right coronary artery, we retrospectively analyzed the incidence of bradyarrhythmias and hypotension during occlusion and with reperfusion. RESULTS: Occlusion proximal to the right ventricular branches was identified in 151 (70%) of cases, with occlusions distal but compromising the left ventricular and atrioventricular nodal branches in 65 (30%) others. During occlusion, those with proximal occlusions were more likely to suffer hypotension (41 versus 15%, P=0.0002), advanced atrioventricular block (21 versus 3%, P=0.0008) and hypotension with bradycardia (25 versus 9%, P=0.01). Similarly, reperfusion of proximal occlusions more frequently resulted in abrupt hypotension (42 versus 19%, P=0.002), bradycardia (34 versus 14%, P=0.004) and hypotension with bradycardia (27 versus 12%, P=0.02). CONCLUSIONS: These data demonstrate that during right coronary artery occlusion and with reperfusion, bradycardia and hypotension develop more commonly in patients with proximal occlusions compared with those with distal occlusions. These findings suggest that reflexes arising from the ischemic right ventricle may play a role in bradyarrhythmias and hypotension.

Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device.

BACKGROUND: Local endoscopic mucosal resection of rectal carcinoid tumors is often associated with margin involvement that requires further intervention. The efficacy of resection of these tumors with endoscopic submucosal resection with a ligation device (ESMR-L) was evaluated. METHODS: Fourteen rectal carcinoid tumors were treated by ESMR-L between 1999 and 2002. ESMR-L was performed with a conventional colonoscope with an attached band-ligator device. For comparison, 14 rectal carcinoid tumors, treated by either endoscopic mucosal resection or polypectomy between 1990 and 1997, were evaluated as historical controls. All tumors were estimated to be 1 cm or less in diameter. OBSERVATIONS: There were no differences between the 2 groups in terms of age, gender, or tumor size. For 6 (43%) patients in the control group, there was tumor involvement at the margin of the resection specimen, whereas all tumors removed by ESMR-L had histopathologically proven negative margins (p < 0.05). The mean vertical resection margin also was significantly deeper in the ESMR-L group (p < 0.05). There was no complication of any procedure. CONCLUSIONS: ESMR-L is technically simple, minimally invasive, and safe for treatment of small rectal carcinoid tumors contained within the submucosa. ESMR-L provides a deeper resection margin compared with that obtained with conventional endoscopic mucosal resection or polypectomy.